Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc.

J.P. Morgan analyst Bryan Smilek initiated coverage of telehealth platform Hims & Hers Health ($HIMS) with a Hold rating and a price target of $32....

J.P. Morgan Assigns Hims & Hers Stock a ‘Hold’ Rating. What’s Behind the Cautious Stance?

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX) and Hims & Hers Health (H...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX) and Hims & Hers Health (HIMS)

Telehealth platform Hims & Hers Health ($HIMS) is strengthening its international presence by expanding into Australia. This marks the company’s fo...

Hims & Hers Health Bolsters International Footprint with Australia Launch

Hims & Hers Health ( ($HIMS) ) has fallen by -7.21%. Read on to learn why. Hims & Hers Health shares fell 7.21% over the past week as investors dig...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HIMS	$28.61	-2.75%	2.70M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HIMS	$28.61	-2.8%	2.70M
3
4
5
6

HIMS

Get Hims & Hers Health, Inc. Data in Excel

Get Hims & Hers Health, Inc. Data in Excel